Daniel Johnson
General Practice · Palm Desert, CANPI 1922611896
Payments from drug & device makers
$1,545,836in general payments, 2019–2025
Across 1,026 payments — averaging $1506.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1.3M
- Anika Therapeutics, Inc.$111K
- AbbVie$31K
- Boehringer Ingelheim Canada Ltd.ltee$24K
- AstraZeneca$24K
- Pfizer$16K
- plus $25K from 5 others
General payments by program year
21
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 957 | $1,316,551 |
| Anika Therapeutics, Inc. | 9 | $110,985 |
| AbbVie | 6 | $30,587 |
| Boehringer Ingelheim Canada Ltd.ltee | 34 | $23,814 |
| AstraZeneca | 2 | $23,763 |
| Pfizer | 7 | $15,532 |
| Janssen Research & Development, LLC | 4 | $12,750 |
| Boehringer Ingelheim | 3 | $11,660 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Acella Pharmaceuticals, LLC | 2 | $39 |
| Johnson & Johnson | 1 | $32 |
How this compares
$1,545,836 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.
Other general practice in Palm Desert
- Hessam AazamiCanoga Park$88.4M
- Frederic MollRedwood City$5.7M
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Bruce TorkanLos Angeles$3.8M
- Bradley ChingUpland$1.4M
- Jared AdamsSan Francisco$862K
- Marina GoldGlendale$784K
- Eric BrassTorrance$755K
- Marc GeissbergerGreenbrae$583K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.